Analytical Services

CMC Studies 

Shilpa Pharma Lifesciences Limited (SPLL) offers wide range of analytical chemistry services and offers best results with minimal timelines. These services could be either integrated with CDMO project or stand-alone project. Proven scientific capabilities, periodical communication and providing requisite data will be helpful to compile CMC documentation as required to support regulatory filings (IND/NDA) of our customers. 

Shilpa Pharma has well qualified scientists and technical leaders who are dedicated in understanding analytical problem / requirements, deriving analytical solutions and serving our customers effectively. 

Structure Elucidation

Read More / Read Less (Version 2)

Structure elucidation is essential in pharmaceutical development for determining the exact molecular structure of compounds such as new chemical entities (NCEs), impurities, degradation products, and metabolites. At Shilpa Pharma, we use a range of advanced spectroscopic techniques—including NMR, mass spectrometry, IR, and UV-Visible spectroscopy—to accurately identify and confirm chemical structures. This supports product development, impurity profiling, and overall compound characterization.
Read more

Impurity Evaluation & Impurity Profiling

Unknown impurities identification by mass spectroscopy - LCMS & GCMS

Nitrosamine impurities quantifications

Non-carryover impurities quantifications 

Genotoxic impurities quantifications

Elemental Impurities quantifications (ICP-OES/MS) – as per ICH Q3D 

Standards Qualification Box

Standards Qualification

Impurities standard qualification
Reference / Working standard qualifications
Analytical Testing Box

Analytical Testing

Quality control testing (Assay, Related substances, Residual solvents, Wet chemical analysis, etc.) for Raw materials, Intermediates and APIs as per customer specification
Quality control testing as per compendial monograph specification
Proposal, review and finalization of Specification along with Standard Testing Procedure (STP)
Thermal analysis
Particle size analysis
Ion-Chromatography analysis

Analytical Testing

Polymorph Profiling

1 Step 1

Evaluation & Identification of Polymorphs

Systematic analysis of solid-state forms to identify potential polymorphs and assess stability characteristics.

2 Step 2

Polymorph Screening & Qualification in NCE/API

Comprehensive screening and qualification of polymorphic forms to ensure optimal characteristics for NCE/API development.

3 Step 3

Quantification & Establishment of Polymorphic Nature

Advanced analytical techniques used to quantify and establish the polymorphic nature in NCE/API formulations.

Polymorph Profiling

Photo-Stability & Forced Degradation Study

Forced degradation studies to showcase the specificity of stability indicating methods and gather essential data for determination of proper storage conditions, packaging and shelf life of product, which are vital for regulatory documentation

Establishing degradation pathways of drug substances

Revealing degradation mechanisms such as hydrolysis, oxidation, thermolysis or photolysis

Establishing degradation pathways of drug substances

Establishing the stability-indicating nature of a developed method 

Understanding the chemical properties of drug molecules

Creating a degradation profile similar to formal stability studies under ICH conditions

Stability Studies

 Analytical Method Transfer

Ensuring that a method developed in a client’s lab functions effectively at our lab, and vice versa, is crucial for maintaining consistency and meeting regulatory requirements. We focus on preserving precision throughout the entire life cycle of the API to ensure that the method is reliable, reproducible, and consistent across different laboratories or facilities.

Shilpa will pay special attention to the following aspects:

Initial Assessment

Review the method and its development history (e.g., method validation results, data from the original lab).

Protocol Preparation

Create a detailed AMT protocol outlining the transfer objectives, acceptance criteria, timeline, and test conditions.

Equipment mapping

Ensure that the receiving lab is equipped with the same or equivalent equipment to guarantee a seamless and effective process.

Final Report

A detailed report documenting the method transfer process, including the results, deviations, and any corrective actions taken.

Countries We Serve in

Fill the Form